Polybenzimidazole compounds
22A PBI compound that includes imidazole nitrogens, at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)MeSiCH-, where R is...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Klaehn, John R Peterson, Eric S Wertsching, Alan K Orme, Christopher J Luther, Thomas A Jones, Michael G |
| description | 22A PBI compound that includes imidazole nitrogens, at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)MeSiCH-, where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least five equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about fifteen equivalents. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07772361</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07772361</sourcerecordid><originalsourceid>FETCH-uspatents_grants_077723613</originalsourceid><addsrcrecordid>eNrjZJAOyM-pTErNq8rMzUxJrMrPSVVIzs8tyC_NSynmYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDc3NzI2MzQmAglAJ_RJPs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Polybenzimidazole compounds</title><source>USPTO Issued Patents</source><creator>Klaehn, John R ; Peterson, Eric S ; Wertsching, Alan K ; Orme, Christopher J ; Luther, Thomas A ; Jones, Michael G</creator><creatorcontrib>Klaehn, John R ; Peterson, Eric S ; Wertsching, Alan K ; Orme, Christopher J ; Luther, Thomas A ; Jones, Michael G ; Battelle Energy Alliance, LLC</creatorcontrib><description>22A PBI compound that includes imidazole nitrogens, at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)MeSiCH-, where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least five equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about fifteen equivalents.</description><language>eng</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7772361$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64015</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7772361$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Klaehn, John R</creatorcontrib><creatorcontrib>Peterson, Eric S</creatorcontrib><creatorcontrib>Wertsching, Alan K</creatorcontrib><creatorcontrib>Orme, Christopher J</creatorcontrib><creatorcontrib>Luther, Thomas A</creatorcontrib><creatorcontrib>Jones, Michael G</creatorcontrib><creatorcontrib>Battelle Energy Alliance, LLC</creatorcontrib><title>Polybenzimidazole compounds</title><description>22A PBI compound that includes imidazole nitrogens, at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)MeSiCH-, where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least five equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about fifteen equivalents.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZJAOyM-pTErNq8rMzUxJrMrPSVVIzs8tyC_NSynmYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDc3NzI2MzQmAglAJ_RJPs</recordid><startdate>20100810</startdate><enddate>20100810</enddate><creator>Klaehn, John R</creator><creator>Peterson, Eric S</creator><creator>Wertsching, Alan K</creator><creator>Orme, Christopher J</creator><creator>Luther, Thomas A</creator><creator>Jones, Michael G</creator><scope>EFH</scope></search><sort><creationdate>20100810</creationdate><title>Polybenzimidazole compounds</title><author>Klaehn, John R ; Peterson, Eric S ; Wertsching, Alan K ; Orme, Christopher J ; Luther, Thomas A ; Jones, Michael G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_077723613</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Klaehn, John R</creatorcontrib><creatorcontrib>Peterson, Eric S</creatorcontrib><creatorcontrib>Wertsching, Alan K</creatorcontrib><creatorcontrib>Orme, Christopher J</creatorcontrib><creatorcontrib>Luther, Thomas A</creatorcontrib><creatorcontrib>Jones, Michael G</creatorcontrib><creatorcontrib>Battelle Energy Alliance, LLC</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Klaehn, John R</au><au>Peterson, Eric S</au><au>Wertsching, Alan K</au><au>Orme, Christopher J</au><au>Luther, Thomas A</au><au>Jones, Michael G</au><aucorp>Battelle Energy Alliance, LLC</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Polybenzimidazole compounds</title><date>2010-08-10</date><risdate>2010</risdate><abstract>22A PBI compound that includes imidazole nitrogens, at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)MeSiCH-, where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least five equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about fifteen equivalents.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_07772361 |
| source | USPTO Issued Patents |
| title | Polybenzimidazole compounds |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T03%3A16%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Klaehn,%20John%20R&rft.aucorp=Battelle%20Energy%20Alliance,%20LLC&rft.date=2010-08-10&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07772361%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |